Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hindra

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Natural Products|September 20, 2014
Strain prioritization for natural product discovery by a high-throughput real-time PCR methodHindra, Tingting Huang, Dong Yang, et al.
BMC Pediatrics|May 29, 2018
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months oldHartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, et al.
BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
Plos Neglected Tropical Diseases|May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases|June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Journal of Natural Products|January 19, 2018
Discovery of Alternative Producers of the Enediyne Antitumor Antibiotic C-1027 with High TitersXiaohui Yan, Hindra, Huiming Ge, et al.
Plos One|February 14, 2019
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Iris Rengganis, et al.
BMC Pediatrics|December 22, 2015
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization scheduleKusnandi Rusmil, Hartono Gunardi, Eddy Fadlyana, et al.
Emerging Infectious Diseases|August 21, 2018
Zika Virus Seropositivity in 1-4-Year-Old Children, Indonesia, 2014R Tedjo Sasmono, Rama Dhenni, Benediktus Yohan, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Natural Products|September 20, 2014
Strain prioritization for natural product discovery by a high-throughput real-time PCR methodHindra, Tingting Huang, Dong Yang, et al.
BMC Pediatrics|May 29, 2018
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months oldHartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, et al.
BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.
Plos Neglected Tropical Diseases|May 3, 2018
Correction: Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Plos Neglected Tropical Diseases|June 16, 2017
Dengue seroprevalence and force of primary infection in a representative population of urban dwelling Indonesian childrenAri Prayitno, Anne-Frieda Taurel, Joshua Nealon, et al.
Journal of Natural Products|January 19, 2018
Discovery of Alternative Producers of the Enediyne Antitumor Antibiotic C-1027 with High TitersXiaohui Yan, Hindra, Huiming Ge, et al.
Plos One|February 14, 2019
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Iris Rengganis, et al.
BMC Pediatrics|December 22, 2015
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization scheduleKusnandi Rusmil, Hartono Gunardi, Eddy Fadlyana, et al.
Emerging Infectious Diseases|August 21, 2018
Zika Virus Seropositivity in 1-4-Year-Old Children, Indonesia, 2014R Tedjo Sasmono, Rama Dhenni, Benediktus Yohan, et al.
Pageof 7